The evolution of the immune reactivity in patients with coronary artery disease under the influence of complex treatment
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
In most cases, the main cause of coronary heart disease is atherosclero sis of the coronary arteries. Inflammation has an important role in the development of atherosclerotic process causes feasibility study of inflammatory markers in patients with coronary heart disease.
The objective: study of inflammatory markers in patients with unstable angina and study their changes during treatment with statins and alpha-lipoic acid.
Patients and methods. The study involved 61 patients with unstable angina. Depending on the therapeutic management, patients divided into two groups, the first group received conventional treatment with rosuvastatin, and the second group took the conventional treatment including rosuvastatin in combination with alpha-lipoic acid. Serum of patients were tested for interleukin 1-β, interleukin-6 and C-reactive protein.
Results. Before treatment, patients with unstable angina revealed a significant increase in levels of cytokines and CRP compared to controls. After treatment was found a significant decrease in levels of interleukin 1-β, interleukin-6 and C-reactive protein in the serum of patients of both groups. However, more substantial reduction in these parameters was found in patients who additionally received alpha-lipoic acid.
Conclusions. In patients with unstable angina revealed a significant increase in serum levels of interleukin 1-β, interleukin-6, C-reactive protein. As a result of the treatment found a significant decrease in these parameters. Rosuvastatin combined with alpha-lipoic acid results in a more significant reduction in interleukin 1-β, interleukin-6, C-reactive protein.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Беловол А.Н. Альфа-липоевая кислота: от фармакологических свойств к клиническому применению / А.Н. Беловол, И.И. Князькова // Ліки України. – 2015. – No 7. – С. 4–10.
Королева О.С. Биомаркери в кардиологии: регистрация внутрисосудистого воспаления / О.С. Королева, О.Д. Затейщиков // Фарматека. – 2007. – No 8/9. – С. 30–36.
Лутай М.И. Роль дисфункции эндотелия, воспаления и дислипидемии в атерогенезе / М.И. Лутай, И.П. Голикова, В.А. Слободской // Український кардіологічний журнал. – 2007. – No 5. – С. 34–37.
Міщенко Л.А. Ефективність розувастатину (Клівас) у пацієнтів з ішемічною хворобою серця (результати відкритого проспективного дослідження «Чисті судини» / Л.А. Міщенко // Український медичний часопис. – 2016. – No 3 (113). – С. 98–100.
Милютина О.В. Прогностическая роль С-реактивного белка в развитии риска кардиальных событий / О.В. Милютина, Е.Н. Чичерина // Российский кардиологический журнал. – 2011. – No 1 (87). – С. 71–73.
Пархоменко А.Н. Применение статинов у больных высокого риска: путь от ожидания к клинической практике / О.М. Пархоменко // Український медичний часопис. – 2010. – No 5 (79). – С. 67–71.
Симбирцев А.С. Цитокины: классификация и биологические функции / А.С. Симбирцев // Цитокины и воспаление. – 2004. – No 2. – С. 16–22.
Талаева Т.В. Значимость и механизмы действия воспаления как независимого фактора атерогенеза / Т.В. Талаева, А.С. Гавриш, В.В. Братусь // Український кардіологічний журнал. – 2014. – No 4. – С. 49–69.
Хіміон Л.В. Переваги та перспективи широкого використання статинів у загальнолікарській практиці / Л.В. Хіміон // Мистецтво лікування. – 2011. – No 2. – С. 38–46.
Шульпекова Ю.О. Применение тиоктовой кислоты в гастроэнтерологии / Ю.О. Шульпекова, В.Т. Ивашкин // Русский медицинский журнал. – 2000. – No 15. – С. 630.
Gomes M.B. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic disease / M.B. Gomes, C.A. Negrato // Diabetology and Metabolic Syndrome. 2014. – Vol. 6. – P. 80.
Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study / S. Sola, M.Q. Mir [et al.] // Circulation. – 2005. – Vol. 111 (3). – P. 343–348.
Flaxseed oil and α-lipoic acid combination reduces atherosclerosis risk factors in rats fed a high fat diet / J. Xu, W. Yang [et al.] // Lipids in Health and Disease. – 2012. – Vol. 11. – P. 148.
Kones R. Rosuvastatin, inflammation, C reactive protein, JUPITER, and primary prevention of cardiovascular disease—a perspective / R. Kones // Drug Des Devel Ther. – 2010. – Vol. 4. – P. 383–413.
Morton A.C. The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non ST elevation acute coronary syndromes: the MRC ILA Heart Study / A.C. Morton, A.M. Rothman // Eur Heart J. – 2015. – Vol. 36 (6). – P. 377–384.
Lipid profile and cytokines interactions during successful aging / I. Pantsulaia, M. Iobadze [et al.] // Georgian Med News. – 2015. – Vol. 243. – P. 46–51.
Paoletti R. Inflammation in atherosclerosis and implications for therapy / R. Paoletti, A.M. Gotto, D.P. Hajjar // Circulation. – 2004. – Vol. 109 (Suppl III). – P. 20–26.
Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort / K.W. Lee, J.S. Hill [et al.] // CMAJ. – 2006. – Vol. 174 (4). – P. 461–466.
Serum cytokine tumor necrosis factor alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden? / I. Gotsman, A. Stabholz [et al.] // Isr Med Assoc J. – 2008. – Vol. 10 (7). – P. 494–498.
Vasdev S. Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats / S. Vasdev, C.A. Ford [et al.] // Journal of Hypertension. – 2000. – Vol. 18 (5). – P. 567–573.
Waller B.F. Nonatherosclerotic coronary heart disease // The Heart / S.W. Hurst, ed. – New York : McGraw Hill, 1994. – P. 1239–1261.
Wray D.W. Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption / D.W. Wray, S.K. Nishiyama, R.A. Harris // Hypertension. – 2012. – Vol. 59 (4). – P. 818–824.
